Additionally, there were antiangiogenic responses in DCP-IL-12/FLT3L-treated melanomas (Fig. 2k), which could have involved both direct vascular-pruning effects of IFNγ27 and indirect mechanisms; for example, through M1-programmed (angiostatic) TAMs28. The gene discussed is FLT3LG; the disease is melanoma.